1. Home
  2. EZPW vs COLL Comparison

EZPW vs COLL Comparison

Compare EZPW & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EZPW
  • COLL
  • Stock Information
  • Founded
  • EZPW 1989
  • COLL 2002
  • Country
  • EZPW United States
  • COLL United States
  • Employees
  • EZPW N/A
  • COLL N/A
  • Industry
  • EZPW Other Specialty Stores
  • COLL Biotechnology: Pharmaceutical Preparations
  • Sector
  • EZPW Consumer Discretionary
  • COLL Health Care
  • Exchange
  • EZPW Nasdaq
  • COLL Nasdaq
  • Market Cap
  • EZPW 860.3M
  • COLL 864.7M
  • IPO Year
  • EZPW 1991
  • COLL 2015
  • Fundamental
  • Price
  • EZPW $13.96
  • COLL $30.23
  • Analyst Decision
  • EZPW Strong Buy
  • COLL Strong Buy
  • Analyst Count
  • EZPW 3
  • COLL 5
  • Target Price
  • EZPW $17.83
  • COLL $43.80
  • AVG Volume (30 Days)
  • EZPW 2.1M
  • COLL 321.1K
  • Earning Date
  • EZPW 04-28-2025
  • COLL 05-08-2025
  • Dividend Yield
  • EZPW N/A
  • COLL N/A
  • EPS Growth
  • EZPW 18.94
  • COLL N/A
  • EPS
  • EZPW 1.19
  • COLL 1.25
  • Revenue
  • EZPW $1,202,458,000.00
  • COLL $664,283,000.00
  • Revenue This Year
  • EZPW $9.68
  • COLL $20.00
  • Revenue Next Year
  • EZPW $6.36
  • COLL $3.74
  • P/E Ratio
  • EZPW $11.53
  • COLL $24.13
  • Revenue Growth
  • EZPW 8.14
  • COLL 17.17
  • 52 Week Low
  • EZPW $9.65
  • COLL $23.23
  • 52 Week High
  • EZPW $16.60
  • COLL $42.29
  • Technical
  • Relative Strength Index (RSI)
  • EZPW 35.02
  • COLL 64.41
  • Support Level
  • EZPW $13.58
  • COLL $28.81
  • Resistance Level
  • EZPW $15.05
  • COLL $30.17
  • Average True Range (ATR)
  • EZPW 0.49
  • COLL 1.02
  • MACD
  • EZPW -0.24
  • COLL 0.37
  • Stochastic Oscillator
  • EZPW 13.10
  • COLL 93.13

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: